The shares of Acasti Pharma Inc. (NASDAQ: ACST) saw a sharp rise when the company reported that its clinical studies were making substantial progress. The
Acasti Pharma Inc. (ACST) shares were rising 22.04% to trade at $0.659 in after-hours at last check. As of the last check, shares of Ascasti
Greenpro Capital Corp. (GRNQ), a Conglomerates company, dropped about -5.88% at $1.76 in pre-market trading Tuesday after announcing Bitcoin fund. ATIF Holdings Limited (ATIF) stock
Avinger Inc. (AVGR) stock plunged -7.38% to $0.4445 in the pre-market trading. The most recent rating by Ladenburg Thalmann, on March 09, 2018, is a
Ocugen Inc. (OCGN) stock plunged -8.85% to $2.37 in the pre-market trading after reporting the appointment of a vaccine scientific advisory board comprised of leading
Ocugen Inc. (OCGN) stock soared 77.6% to $1.43 in the pre-market trading after signing a binding letter of intent (LOI) with Bharat Biotech to develop
Lizhi Inc. (LIZI) stock plunged -8.14% to $4.4 in the pre-market trading after reporting that it entered in-car audio collaboration with Xpeng Motors. The most
BlackBerry Limited (BB) stock soared 21.29% to $8.49 in the pre-market trading following the announcement of its multi-year, global agreement with Amazon Web Services, Inc.
AnPac Bio-Medical Science Co. Ltd. (ANPC) stock plunged 0.0% to $7.14 in the pre-market trading after announcing that it experienced strong demand for its cancer
Oncternal Therapeutics Inc. (ONCT) stock soared 2.42% to $2.96 in the pre-market trading as the company raised the size of the formerly publicized offering and
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.